BOA Annual Congress 2026 early bird registration is now open for BOA members and non–members.
BOA members can register with a 100% discount on the ticket fee for an extended time. Discounted period will run until Sunday 19th July 2026.
Author: Garreth
A moment to reflect and a moment to act
by Adrian Bradley, CEO, Arthritis and Musculoskeletal Alliance (ARMA)
As we approach publication of ARMA’s new five-year strategy, this feels like an important moment to pause and reflect on the state of musculoskeletal (MSK) health, our sector, and our Alliance.
The challenges are clear. Community MSK waiting lists remain among the longest in the NHS, leaving too many people waiting in persistent pain and unable to work, care for family, or participate fully in everyday life. In many areas, MSK health still lacks clear system leadership.…
Read more of this article
PCRMM Essentials of MSK Injections course
Saturday, 9th May, 2026, at the The Royal Orthopaedic Hospital, Birmingham
The Essentials of MSK Injections: Landmark and Ultrasound-Guided course is a comprehensive, hands-on training programme designed to equip clinicians with the knowledge and practical skills required to perform musculoskeletal injections safely and effectively in clinical practice.
This course focuses on the most performed MSK injections, covering both landmark-guided and ultrasound-guided techniques. As one of the first courses of its kind to combine both approaches in a single structured curriculum, it provides a unique opportunity to develop a dual skill set, making it easier for clinicians to learn, understand, and apply both techniques in real-world settings.…
Read more of this article
Celebrating Christina Cunliffe OBE
The RCC President-Elect, Stuart Smellie and Chief Executive, Susie Isaacson were delighted to be invited to share the formal celebrations as Professor Christina Cunliffe OBE, Principal of McTimoney College of Chiropractic was awarded her Order of the British Empire (OBE) from the Princess Royal at Windsor Castle.
This was a proud moment to celebrate all of Christina’s many achievements and she was joined by family, friends, colleagues, patients and members of the chiropractic community. We were delighted to share this momentous occasion to celebrate Christina’s personal ambition and all that she represents for the profession as a whole.…
Read more of this article
SOMM Patient Information Leaflet
The SOMM team has developed a clear, accessible, and evidence‑informed aftercare advice leaflet to support patient safety, optimal outcomes, and integrated rehabilitation following steroid injection treatment.
This new high‑quality Patient Information Leaflet (PIL) provides simple, practical guidance for both clinicians and patients after a musculoskeletal steroid injection in any clinical setting.
Key Features
- Clear & easy to read
- Written to an approximate reading age of 11, ensuring accessibility for patients with a wide range of literacy levels. The leaflet helps patients understand their post‑injection care and encourages confidence, adherence, and engagement in their rehabilitation plan.
Read more of this article
New RA & Menopause booklet
On International Women’s Day March 8th 2026, the National Rheumatoid Arthritis Society (NRAS) launched a new Rheumatoid Arthritis & Menopause booklet, which will be available to download or order in print free of charge. The resource addresses a long‑standing gap in support for women managing both rheumatoid arthritis (RA) and the menopause—two conditions that can overlap in complex and often confusing ways.
The booklet follows a 2024 NRAS study exploring women’s experiences of RA during menopause. The findings revealed a striking lack of clinical discussion: 93% of respondents said no healthcare professional had ever raised the topic with them.…
Read more of this article
NRAS cardiovascular risk modules
The National Rheumatoid Arthritis Society (NRAS) has introduced three new cardiovascular risk management modules to its SMILE‑RA e‑learning programme this February.
People with rheumatoid arthritis (RA) face a significantly higher risk of cardiovascular disease (CVD)—around 1.5 times that of the general population—yet screening and management of these risks remain inconsistent across the UK.
Although guidelines such as NICE NG100 highlight the importance of regular cardiovascular checks for people with RA, many individuals still have undiagnosed or poorly managed risk factors. International audits show this is a widespread issue, regardless of healthcare system, and contributes to the persistently elevated CVD risk seen in RA.…
Read more of this article
The MSK health innovation ecosystem
New report into MSK innovation ecosystem
Orthopaedic Research UK (ORUK) has launched a State of the Musculoskeletal health innovation ecosystem report. It is a synthesis of two new research studies commissioned by ORUK – business data analysis Beauhurst has identified and analysed innovative MSK companies (including spinouts) in the UK; meanwhile, academic researcher Businessable has produced a dataset and subject analysis of those involved in MSK research in the UK.
The purpose of these research studies is to improve understanding of the MSK health innovation ecosystem and ensure that support is focused on the right areas.…
Read more of this article
Early diagnosis of osteoporosis study
Keele to lead new study to improve early diagnosis of osteoporosis
A Keele University–led team has secured £4.8 million from the National Institute for Health and Care Research (NIHR) to improve early identification of osteoporosis among at-risk and under-served patients in primary care.
Led by Professor Zoe Paskins, the PROTECTS study will design, implement and evaluate a new digital bone health model of care in general practice (GPs). This model will enable earlier treatment, prevent fractures, reduce pressure on the NHS, and provide economic evidence to inform decisions on targeted osteoporosis screening.…
Read more of this article
One month to the Psoriasis Association Annual Meeting
‘Challenges, Opportunities and Solutions’
Saturday, 20 June 2026
Places are still available for this event, which is set to explore developments in treatments, research and patient support for psoriasis and psoriatic arthritis.
This year’s conference is proudly CPD certified – so all attendees that would like a certificate for their attendance will have one supplied from The CPD certification service on behalf of The Psoriasis Association following the event.
Location: Convene (etc Venues), 11 Portland Street, Manchester, M1 3HU.
For more information and to grab your ticket, visit the Psoriasis Association website.